Evidence map›Paper›PMID 34283078›Full record

ArticleCancers2021

Blood Arsenic Levels as a Marker of Breast Cancer Risk among

Wojciech Marciniak, Tomáš Matoušek, Susan Domchek, Angelo Paradiso, Margherita Patruno, Arvids Irmejs, Irita Roderte, Róża Derkacz, Piotr Baszuk, Magdalena Kuświk and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 6 countries.

Wojciech MarciniakDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Tomáš MatoušekInstitute of Analytical Chemistry of the Czech Academy of Sciences, 602 00 Brno, Czech Republic.ORCID 0000-0002-7603-1773
Susan DomchekBasser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.
Angelo ParadisoCenter for Hereditary Tumors Research, Istituto Tumori Bari, Giovani Paolo II, IRCCS, 70124 Bari, Italy.
Margherita PatrunoCenter for Hereditary Tumors Research, Istituto Tumori Bari, Giovani Paolo II, IRCCS, 70124 Bari, Italy.
Arvids IrmejsDepartment of Surgery, Institute of Oncology, Riga Stradins University, Pauls Stradins Clinical University Hospital, LV-1007 Rīga, Latvia.
Irita RoderteDepartment of Surgery, Institute of Oncology, Riga Stradins University, Pauls Stradins Clinical University Hospital, LV-1007 Rīga, Latvia.
Róża DerkaczDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0002-2904-5259
Piotr BaszukDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Magdalena KuświkDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0001-9070-747X
Cezary CybulskiDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Tomasz HuzarskiDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Jacek GronwaldDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0002-3643-2871
Tadeusz DębniakDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Michał FalcoWest Pomeranian Oncology Center, Radiation Oncology Department, 71-730 Szczecin, Poland.
Marcin R LenerDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0003-0747-4850
Anna JakubowskaDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0002-5650-0501
Katherine PullellaDepartment of Nutritional Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.
Joanne KotsopoulosDalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.
Steven NarodFamilial Breast Cancer Research Unit, Women's College Research Institute, Toronto, ON M5G 1N8, Canada.
Jan LubińskiDepartment of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0003-2931-3003
Read-Gene (Poland) · PLPomeranian Medical University · PLIstituto Tumori Bari · ITPauls Stradiņš Clinical University Hospital · LVUniversity of Toronto · CACzech Academy of Sciences, Institute of Analytical Chemistry · CZUniversity of Pennsylvania · USWomen's College Hospital · CA

Funding

Narodowe Centrum Badań i Rozwoju INNOMED/1/16/NCBR/2014
6 · The paper itself

Abstract

An important group of breast cancers is those associated with inherited susceptibility. In women, several predisposing mutations in genes involved in DNA repair have been discovered. Women with a germline pathogenic variant in

Indexed as

blood arsenicBRCA1 carriersbreast cancercancer riskepidemiologyprospective cohort

Identifiers

PMID34283078
PMCPMC8269342
OpenAlexW3181730936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.